Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Scribe Therapeutics, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Figures computed from official regulatory filings — .
Business description unavailable in our sources.
SEC company identity · Nov 2, 2026
Purchases and sales · full history
9 buysbar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| GORDON CARL Ltrack record | Buy | $15M | conv 86ClusterUnusual size+1 | SEC | |
| Doudna Jennifer A | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
| GORDON CARL Ltrack record | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| ORBIMED ADVISORS LLCtrack record | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| AH Bio Fund II, L.P. | Buy | $5M | conv 55ClusterFirst in 12mo | SEC | |
| Doudna Jennifer A | Other | n/a (No price was disclosed in the filing) | SEC | ||
| AH Bio Fund II, L.P. | Other | n/a (No price was disclosed in the filing) | SEC | ||
| ORBIMED ADVISORS LLCtrack record | Other | n/a (No price was disclosed in the filing) | SEC | ||
| AH Bio Fund II, L.P. | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| GORDON CARL Ltrack record | Other | n/a (No price was disclosed in the filing) | SEC | ||
| ORBIMED ADVISORS LLCtrack record | Buy | $15M | conv 81ClusterUnusual size | SEC | |
| AH Bio Fund II, L.P. | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| AH Bio Fund II, L.P. | Other | n/a (No price was disclosed in the filing) | SEC | ||
| Staahl Brett | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Staahl Brett | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Aghazadeh Behzadtrack record | Buy | $144.3K | conv 33Cluster | SEC | |
| Aghazadeh Behzadtrack record | Buy | $1.1M | conv 39ClusterFirst in 12mo | SEC | |
| Aghazadeh Behzadtrack record | Buy | $35M | conv 70ClusterFirst in 12mo | SEC | |
| Staahl Brett | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Parrot David | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Parrot David | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Oakes Benjamin L. | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Lucas Svetlana | Buy | $45K | conv 64 | SEC | |
| Oakes Benjamin L. | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Watson James Dean | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |